Article Figures & Data
Figures
- Figure 1.
2008, 2013, 2019 Comparison of responses of US family medicine residencies to a national survey concerning industry interactions with and access to trainees.
Tables
- Table 1.
2019 CERA Program Director Survey Questions: Pharmaceutical Industry Interaction in US Family Medicine Residencies
Survey Question Response Options Does your residency allow gifts from industry or industry-supported food? ▪ Yes
▪ No
Are drug samples accepted at the residency? ▪ Yes
▪ No
Are industry representatives allowed access to medical students and/or residents at the family medicine center? (Note: This does not include access required for device training, such as Nexplanon)* ▪ Yes
▪ No
Are any industry-sponsored residency activities allowed? ▪ Yes
▪ No
Does your residency have a formal curriculum that explores the interactions between physicians and the pharmaceutical industry? ▪ Yes
▪ No
In the past five years how has your program’s interaction with the pharmaceutical industry changed? (through samples, visits from representatives, gifts/food, and sponsored activities): ▪ Increased
▪ Decreased
▪ Stayed the same
▪ Don’t know
If decrease: What were the major factors that led to a decrease in pharmaceutical interaction? (Pick all that apply) ▪ Local response to national legislation (2013 Sunshine Act requiring documentation of all gifts)
▪ Ethical concerns
▪ Resident input
▪ Faculty input
▪ Institutional policy
▪ Other
If increase: What were the major factors that led to an increase in pharmaceutical interaction? (Pick all that apply) ▪ Resident input
▪ Faculty input
▪ Need for samples
▪ Resources (e.g. food for lunches)
▪ Institutional policy
▪ Educational factors (e.g., exposure to teach interaction)
▪ Other
↵* The device clarification was added in the 2019 survey based on some feedback from pre-survey peer review and our 2013 study.
